| abstract |
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof, which is an inhibitor of a voltage-gated sodium channel, particularly Nav1.7. □ These compounds are useful in the treatment of diseases which can be treated by inhibition of sodium channels, such as pain conditions. Pharmaceutical compositions containing a compound of the invention are also provided. |